Additionally, PCIF1 regulates the TGF-β and interferon-gamma (IFN-γ) signaling pathways through m6Am-dependent mechanisms, thereby influencing the tumor microenvironment and response to immunotherapy [264, 266]. This evidence concerns the gene IFNG and neoplasm.